AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed cashed in on a stock surge and Third Harmonic kicked off a drug auction.

Akeso claims another PD-1/VEGF win; FDA requests more data from Novavax

Xenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy

March 10, 2026

Cobalt mine in DRC poisoning communities, displacing thousands – Report – EnviroNews

March 10, 2026

Source link

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans

Xenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy

Cobalt mine in DRC poisoning communities, displacing thousands – Report – EnviroNews

Pro-Iran Groups in Iraq Demand US Troops Leave, Warn of Regional Escalation

Apple’s Liquid Glass design is paving the way for AR glasses

Apple's Liquid Glass design is paving the way for AR glasses

Leave a Reply Cancel reply

RECOMMENDED NEWS

Egypt resorts to gas import as natural gas output plummets

Sniffing nanoparticles loaded with mRNA could lead to advanced lung therapeutics

Google Search can now help you solve geometry, physics and calculus problems

DR Congo: Crackdown on Opposition Ahead of Elections

POPULAR NEWS

Mahama attends Liberia’s 178th independence anniversary

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

AstraZeneca forms an AI deal in China; Third Harmonic advances liquidation plans

Related posts

Pro-Iran Groups in Iraq Demand US Troops Leave, Warn of Regional Escalation

Apple’s Liquid Glass design is paving the way for AR glasses

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS